The standard treatment for glioblastoma is to remove the tumor mass, clean the margins with radiation therapy, and then administrator either the alkylating agent Temozolomide (TMZ) or Bevacizumab, an inhibitor of vascular endothelial growth factor (VEGF)]5–7. This evidence concerns the gene VEGFA and glioblastoma.